Treatment Patterns, Healthcare Resource Utilization, and Costs Among Medicare Patients with Multiple Sclerosis in Relation to Disease-Modifying Therapy and Corticosteroid Treatment
Crossref DOI link: https://doi.org/10.1007/s40120-018-0123-y
Published Online: 2018-12-18
Published Print: 2019-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sanchirico, Marie
Caldwell-Tarr, Amanda
Mudumby, Pallavi
Hashemi, Lobat
Dufour, Robert
Funding for this research was provided by:
Sanofi
Article History
Received: 8 August 2018
First Online: 18 December 2018